Crossmark

Defining ‘gut health’: a leap forward, but still some road to travel

Crossref DOI link: https://doi.org/10.1038/s41575-026-01189-6

Published Online: 2026-03-17

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mullish, Benjamin H. https://orcid.org/0000-0001-6300-3100
License Information

Text and Data Mining valid from 2026-03-17

Version of Record valid from 2026-03-17
More Information

Article History

First Online: 17 March 2026

Competing interests

: B.H.M. has received consultancy fees from Ferring Pharmaceuticals and speaker fees from Tillotts Pharma.